share_log

Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

Benzinga Real-time News ·  Oct 14, 2022 04:56

Canaccord Genuity analyst Kyle Mikson downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Hold and adjusts the price target from $12.5 to $2.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment